Cite

HARVARD Citation

    Zheng, Y. et al. (2015). The Relationship Between the Adverse Events and Efficacy of Sorafenib in Patients With Metastatic Renal Cell Carcinoma. Medicine. 94 (49), pp. e2222-. [Online]. 
  
Back to record